Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIME-2b: Razuprotafib in NPDR
NCT03197870Phase 2Completed
- Sponsor
- EyePoint Pharmaceuticals
- Start
- Jun 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of razuprotafib, sponsored by EyePoint Pharmaceuticals. Started Jun 2017; status: completed.
02
Drugs
razuprotafib
Beyond the preview
Go deeper on NCT03197870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03197870.